Search Within

Michael Forman Berger

  1. "Barry Taylor"
Formats
  1. Journal Article (48)
  2. Meeting Abstract (32)
  3. Guidelines (1)
  4. Research Letter (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (82)
  2. Department of Pathology and Laboratory Medicine (82)
  3. GSK Faculty (82)
  4. Human Oncology and Pathogenesis Program (82)
  5. Department of Medicine (79)
  6. Solid Tumor Oncology Division (76)

More Groups

People
  1. Barry Taylor (82)
  2. David Solit (66)
  3. Ahmet Zehir (34)
  4. Nikolaus Schultz (34)
  5. David Hyman (33)
  6. Marc Ladanyi (27)

More People

Years
  1. 2023 (1)
  2. 2022 (2)
  3. 2021 (7)
  4. 2020 (9)
  5. 2019 (16)
  6. 2018 (14)

More Years

Publications
  1. Journal of Clinical Oncology (13)
  2. Cancer Research (10)
  3. Cancer Discovery (7)
  4. Clinical Cancer Research (6)
  5. JCO Precision Oncology (6)
  6. Laboratory Investigation (6)

More Publications

Publishers
  1. American Association for Cancer Research (24)
  2. American Society of Clinical Oncology (19)
  3. Nature Publishing Group (16)
  4. Oxford University Press (6)
  5. Nature Research (5)
  6. American Society of Hematology (3)

More Publishers

Results (82)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Associations between cancer predisposition mutations and clonal hematopoiesis in patients with solid tumors
    Journal Article

    Franch-Expósito, S.; Mehine, M.; Ptashkin, R. N.; Bolton, K. L.; Bandlamudi, C.; Srinivasan, P.; Zhang, L.; Goodell, M. A.; Gedvilaite, E.; Menghrajani, K.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Germline pathogenic variants impact clinicopathology of advanced lung cancer
    Journal Article

    Mukherjee, S.; Bandlamudi, C.; Hellmann, M. D.; Kemel, Y.; Drill, E.; Rizvi, H.; Tkachuk, K.; Khurram, A.; Walsh, M. F.; Zauderer, M. G.; more...
    Cancer Epidemiology Biomarkers and Prevention (2022)

    Fulltext@MSK | Save
  • The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers
    Journal Article

    Rosen, E. Y.; Won, H. H.; Zheng, Y.; Cocco, E.; Selcuklu, D.; Gong, Y.; Friedman, N. D.; de Bruijn, I.; Sumer, O.; Bielski, C. M.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • A comprehensive comparison of early-onset and average-onset colorectal cancers
    Journal Article

    Cercek, A.; Chatila, W. K.; Yaeger, R.; Walch, H.; Dos Santos Fernandes, G.; Krishnan, A.; Palmaira, L.; Maio, A.; Kemel, Y.; Srinivasan, P.; more...
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • The context-specific role of germline pathogenicity in tumorigenesis
    Journal Article

    Srinivasan, P.; Bandlamudi, C.; Jonsson, P.; Kemel, Y.; Chavan, S. S.; Richards, A. L.; Penson, A. V.; Bielski, C. M.; Fong, C.; Syed, A.; more...
    Nature Genetics (2021)

    Fulltext@MSK | Save
  • Prevalence and characterization of biallelic and monoallelic NTHL1 and MSH3 variant carriers from a pan-cancer patient population
    Journal Article

    Salo-Mullen, E. E.; Maio, A.; Mukherjee, S.; Bandlamudi, C.; Shia, J. R.; Kemel, Y.; Cadoo, K. A.; Liu, Y.; Carlo, M.; Ranganathan, M.; more...
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save
  • Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNA
    Journal Article

    Gorelick, A. N.; Kim, M.; Chatila, W. K.; La, K.; Hakimi, A. A.; Berger, M. F.; Taylor, B. S.; Gammage, P. A.; Reznik, E.
    Nature Metabolism (2021)

    Fulltext@MSK | Save
  • Targeting germline- and tumor-associated nucleotide excision repair defects in cancer
    Journal Article

    Topka, S.; Steinsnyder, Z.; Ravichandran, V.; Tkachuk, K.; Kemel, Y.; Bandlamudi, C.; Madsen, M. W.; Furberg, H.; Ouerfelli, O.; Rudin, C. M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Utility of serial cfDNA NGS for prospective genomic analysis of patients on a phase I basket study
    Journal Article

    Smyth, L. M.; Reichel, J. B.; Tang, J.; Patel, J. A. A.; Meng, F.; Selcuklu, D. S.; Houck-Loomis, B.; You, D.; Samoila, A.; Schiavon, G.; more...
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save
  • TRK XDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
    Journal Article

    Cocco, E.; Lee, J. E.; Kannan, S.; Schram, A. M.; Won, H. H.; Shifman, S.; Kulick, A.; Baldino, L.; Toska, E.; Arruabarrena-Aristorena, A.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save